Incidence of mace with genotype test guided antiplatelet treatment strategy after PCI

Incidence of mace with genotype test guided antiplatelet treatment strategy after PCI

Bibliographic Details
Main Authors:	S. Ramesh, S. Socrates, M.A. Rajasekar, N. Senguttuvan
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483215005672

Similar Items

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01)

Comparing efficacy of antiplatelet agents in PCI patients heterozygous to CYP2C19*2/*3 mutations
by: S. Ramesh, et al.
Published: (2015-12-01)

Prevalence of CYP2C19 gene polymorphism in patients with acute coronary syndrome undergoing PCI
by: S. Ramesh, et al.
Published: (2014-11-01)

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
by: Abdullah M. Al-Rubaish, et al.
Published: (2020-06-01)

K-MACE and Kernel K-MACE Clustering
by: Soosan Beheshti, et al.
Published: (2020-01-01)

Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI
by: Fucheng Zhang, et al.
Published: (2020-09-01)

Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients
by: Athanasios Moulias, et al.
Published: (2021-08-01)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)

Dual antiplatelet therapy (DAPT) in post-PCI patients beyond one year
by: A.K. Singh, et al.
Published: (2017-11-01)

Ray Robinson with mace.
Published: ()

Northeastern University mace.
Published: ()

Rhinitis induced to mace
by: Sanchez Moreno Gema, et al.
Published: (2011-08-01)

Using troponin I to predict MACE after CABG
by: Siti Elkana Nauli, et al.
Published: (2013-06-01)

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial
by: Xiujin Shi, et al.
Published: (2021-06-01)

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
by: Larisa H. Cavallari, et al.
Published: (2018-04-01)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
by: Yong-zhe Guo, et al.
Published: (2021-08-01)

The antiplatelet therapeutical strategies in dependance on the VEGF-A gene G634C polymorphism in patients with acute myocardial infarction with ST segment elevation after successful PCI
by: Inna Kutia
Published: (2020-05-01)

Incidence of clopidogrel resistance in 100 patients undergoing PCI
by: M. Vivek, et al.
Published: (2017-11-01)

A PCI/PCI-X test card for I/O system verification
by: Mitby, Amy K. (Amy Kirsten), 1979-
Published: (2014)

The development of the MACE work-family enrichment instrument
by: Marissa de Klerk, et al.
Published: (2013-11-01)

Types of maces in the culture of Early Medieval Prussians
by: Kulakov V.I.
Published: (2019-06-01)

‘Mace sign’- A definitive sign of trichotillomania?
by: Subrata Malakar, et al.
Published: (2017-10-01)

Superior effect of Heparin and dual antiplatelet therapy on infarct related artery in acute MI patients on FMC prior to PCI
by: D. Kahali, et al.
Published: (2015-12-01)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
by: Solheim Svein, et al.
Published: (2013-01-01)

ORIGINAL PAPER<br> Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention
by: Leszek Markuszewski, et al.
Published: (2006-03-01)

Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome
by: Huilong Duan, et al.
Published: (2019-01-01)

Sünen-i İbn Mâce'nin (Nüshalarının) Rivâyeti
by: James Robson, et al.
Published: (2015-11-01)

The importance of design in nanoarchitectonics: multifractality in MACE silicon nanowires
by: Stefania Carapezzi, et al.
Published: (2019-10-01)

Aspirin resistance and major adverse cardiovascular events (MACEs)
by: CHEN, YA-YU, et al.
Published: (2017)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Triple versus dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) – Our hospital experience
by: Karandeep Singh, et al.
Published: (2015-12-01)

“Unsuitable for PCI…” Multivessel primary PCI. But for whom?
by: Manuel de Sousa Almeida
Published: (2014-02-01)

System Level Assertion-Based Verification Environment for PCI/PCI-X and PCI-Express
by: Chien-Chih Yu, et al.
Published: (2004)

The Influence of Use Artery-Femoral Band (ARFEBAND) to Haematom Incident in Patients After Percutaneus Coronary Intervention (PCI)
by: Junait Junait, et al.
Published: (2018-11-01)

Metal-Assisted Catalytic Etching (MACE) for Nanofabrication of Semiconductor Powders
by: Kurt W. Kolasinski
Published: (2021-06-01)

On the changing seasonal cycles and trends of ozone at Mace Head, Ireland
by: D. C. Carslaw
Published: (2005-01-01)

The mace and the axe in the Iranian martial tradition, by Manouchehr Moshtagh Khorasani
by: Manouchehr Moshtagh Khorasani
Published: (2012-07-01)

Rotation-invariant filters design via BPOF and MACE techniques
by: Yau Jing Jou, et al.
Published: (1993)

Outcomes After PCI in Patients with LV Dysfunction
by: M Ravikiran, et al.
Published: (2017-06-01)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.
by: Dawid L Staudacher, et al.
Published: (2016-01-01)